Victor Stefanescu

2 weeks ago | dailyitem.com | Victor Stefanescu

MINNEAPOLIS — U.S. Food and Drug Administration approvals of life-changing, high-risk medical devices reportedly slowed to a 10-year low for the January to March period, as sources say recent layoffs have had devastating effects.

3 weeks ago | startribune.com | Victor Stefanescu

With a key regulatory approval secured in Europe, Abbott Laboratories is joining the race to commercialize technology that offers a new way to treat a common heart arrhythmia causing strokes.

1 month ago | startribune.com | Victor Stefanescu

3M spinoff Solventum revealed Thursday that its previously reported restructuring eliminated 800 positions, including 110 in Minnesota, and will result in $120 million in annual savings. The restructuring also carried aone-time price tag of $120 million for Solventum, Minnesota's newest large public corporation, according to a presentation for investors Thursday.

1 month ago | startribune.com | Victor Stefanescu

By Victor Stefanescu "This move will help correct imbalances in how pharmacies are paid for brand and generic drugs and will ensure greater access to medicines for patients across the country," Conway said. The elimination of up to 25% of reauthorizations, focusing first on approximately 80 drugs, makes up more than 10% of Optum Rx's prior authorizations, the company said.

1 month ago | thebrunswicknews.com | Victor Stefanescu

The U.S. Food and Drug Administration on Tuesday announced a Class 1 recall - the most serious level - affecting more than 26,000 Medtronic devices used to treat brain aneurysms. The recall comes after four reported deaths and 17 injuries. The recall affects two versions of the device. For its Pipeline Vantage 021 models, Medtronic is updating the instructions for use. And for the Pipeline Vantage 027 model, the company is asking doctors to return them, the agency said.